$OCDX News
Last published 1w ago
- 1w agoOCDXQuidelOrtho Q3 2026 Earnings Conference Call - ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLCEarnings Call TranscriptsWelcome to the Quidel Ortho 3rd Quarter 2026 Financial Results Conference Call and Webcast. At this time, all participants' lines are in a listen-only mode. For those of you participating in the conference call, there wi
- 5mo agoOCDXJeffries Global Healthcare Conference in New YorkORTHO CLINICAL DIAGNOSTICS HOLDINGS PLCEarnings Call TranscriptsOkay. We're going to kick it off. I'm Tycho Peterson from the Life Science Team. It's my pleasure to introduce Quidel Ortho. So why don't we jump into it, Brian? Maybe just starting with a quick look back on some of the
- 6mo agoOCDXQuidelOrtho Q1 2026 Earnings Conference CallORTHO CLINICAL DIAGNOSTICS HOLDINGS PLCEarnings Call TranscriptsWelcome to the first quarter 2026 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode. For those of you participating in the conference call, there will be an oppo
- 8mo agoOCDXRAYMOND JAMES 47TH ANNUAL INSTITUTIONAL INVESTORS CONFERENCE - ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLCEarnings Call TranscriptsBring us at the Raymond James Institutional Investor Conference. I'm Andrew Cooper. I cover diagnostics and life science tools here for Raymond James. Happy to be joined by the Quidel Ortho team. We have CEO Brian Blazer
- 4y agoOCDXQDELQuidel and Ortho Announce Expected Closing of Ortho TransactionGlobeNewswireSAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ:QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc ("Or
- 4y agoOCDXQDELQuidel and Ortho Announce Expected Closing of Ortho TransactionBusiness WireQuidel Corporation (NASDAQ:QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc ("Ortho"), one of the world's larger pure-play in
- 4y agoOCDXQDELOrtho Clinical Diagnostics Shareholders Approve Quidel TransactionGlobeNewswireRARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) ("Ortho" or the "Company"), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a preliminary vot
- 4y agoOCDXOrtho Clinical Diagnostics Reports First Quarter 2022 ResultsGlobeNewswireHighlights • Core revenue declined (0.9%) to $495.0 million, and grew 0.6% in constant currency and 4.2% excluding CoV-2 assay sales, which was a 4% headwind • Growth, excluding CoV-2 assay sales, was driven by Americas, EMEA, and ASPAC regions
- 4y agoOCDXOrtho Clinical Diagnostics Holdings plc (OCDX) Q1 2022 Earnings Call TranscriptEarnings Call TranscriptsOCDX earnings call for the period ending March 31, 2022.
- 4y agoOCDXOrtho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 SolutionGlobeNewswireRARITAN, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a prestigious Gold 2022 Edison Award for its VITROS® A
- 4y agoOCDXOrtho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022GlobeNewswireRARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2022 ended April
- 4y agoOCDXOrtho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and SupportGlobeNewswireRARITAN, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been awarded a Bronze 2022 Stevie® Award for Sales and Customer Service Departme
- 4y agoOCDXOrtho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 ResultsGlobeNewswireHighlights • Fourth quarter Core revenue grew 3.5% to $518.9 million, or 4.3% in constant currency and 8.0% excluding CoV-2 assay sales • Fiscal year Core revenue grew 16.1% to $2.01 billion, or 14.6% in constant currency and 15.7% excluding
- 4y agoOCDXOrtho Clinical Diagnostics Holdings plc (OCDX) Q4 2021 Earnings Call TranscriptEarnings Call TranscriptsOCDX earnings call for the period ending December 31, 2021.
- 4y agoOCDXOrtho Clinical Diagnostics Holdings Plc ("Ortho"): Notice of UK Court Scheme Directions HearingGlobeNewswireRARITAN, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Further to the joint announcement by Ortho and Quidel Corporation ("Quidel") on December 23, 2021 of the signing of a definitive business combination agreement, Ortho announces that, as a preliminary pro
- 4y agoOCDXOrtho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021GlobeNewswireExpects 4Q Reported and Constant Currency Core Revenue Growth of ~4%Fiscal Year Reported and Constant Currency Core Revenue Growth of ~16% and ~15%, respectively RARITAN, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holding
- 4y agoOCDXOrtho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireRARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to part
- 4y agoNKLAWYNNCROXTSLA+9Stocks making the biggest moves midday: Nikola, Las Vegas Sands, Stitch Fix, Crocs and moreCNBCThese are the stocks posting the largest moves in midday trading.
- 4y agoEFOILVSNKLAOCDX+1Thinking about buying stock in Radius Health, Nikola Corp, Ortho Clinical Diagnostics, Energy Focus, or Las Vegas Sands?PR NewswireNEW YORK, Dec. 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RDUS, NKLA, OCDX, EFOI, and LVS.
- 4y agoTSLASFIXNVAX9618-HK+12Stocks making the biggest moves premarket: Novavax, Tesla, JD.com Nikola and othersCNBCThese are the stocks posting the largest moves before the bell.
- 4y agoOCDXQDELQuidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical DiagnosticsBusiness WireStrategic, transformational acquisition advances Quidel's global leadership in diagnostics Transaction Highlights Brings together highly complementary diagnostic portfolios with world-class technologies and platforms spanning high-throughput sys
- 4y agoOCDXOrtho Clinical Diagnostics to Participate in the 4th Annual Evercore ISI HealthCONx ConferenceGlobeNewswireRARITAN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to participate in
- 5y agoOCDXOrtho Clinical Diagnostics Reports Third Quarter 2021 ResultsGlobeNewswireStrong Revenue Growth Drives Financial Results Company Raises Fiscal 2021 Guidance Across all Key Metrics Highlights Third quarter revenue increased 15.8% to $522.5 million, or 14.3% in constant currency Core revenue grew 14.8% to
- 5y agoOCDXOrtho Clinical Diagnostics Holdings plc (OCDX) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsOCDX earnings call for the period ending September 30, 2021.
- 5y agoOCDXOrtho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021GlobeNewswireRARITAN, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it will report results for its third quarter 2021 ended October
- 5y agoOCDXOrtho Customers Rank Company No. 1 in Service and Support for Sixth Consecutive YearPR NewswireCompany receives top customer rating across six categories in the 2021 IMV ServiceTrak™ Awards RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) today announced that for the sixth consecutive year
- 5y agoOCDXOrtho Clinical Diagnostics Announces Launch of New ISXM CapabilitiesPR NewswireNew Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest p
- 5y agoOCDXOrtho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Ordinary SharesGlobeNewswireRARITAN, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) (the "Company"), one of the world's largest pure-play in vitro diagnostics companies, today announced the closing (the "Closing") of the previously
- 5y agoOCDXOrtho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary SharesGlobeNewswireRARITAN, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) (the "Company"), one of the world's largest pure-play in vitro diagnostics companies, today announced the pricing of the previously announced underw
- 5y agoOCDXOrtho Clinical Diagnostics Announces Secondary Offering of Ordinary SharesGlobeNewswireRARITAN, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) (the "Company"), one of the world's largest pure-play in vitro diagnostics companies, today announced that one of its shareholders (the "Selling Sha
- 5y agoOCDXOrtho Clinical Diagnostics to Participate in September Investor ConferencesGlobeNewswireRARITAN, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to par
- 5y agoOCDXOrtho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody TestPR Newswire-- Ortho's new VITROS® Anti-SARS-CoV-2 Total N test detects the individual's immune response to the COVID-19 virus and is intended to help clinicians understand if their patient had a recent or prior COVID-19 infection. -- Ortho is the first comp
- 5y agoOCDXOrtho Clinical Diagnostics Reports Second Quarter 2021 ResultsGlobeNewswireStrong Revenue Growth Drives Financial Results Company Raises Fiscal 2021 Guidance Across all Key Metrics RARITAN, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX), one of the world's largest pure-pla
- 5y agoOCDXOrtho Clinical Diagnostics Holdings plc (OCDX) Q2 2021 Earnings Call TranscriptEarnings Call TranscriptsOCDX earnings call for the period ending June 30, 2021.
- 5y agoOCDXORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in CanadaPR NewswireRARITAN, N.J., July 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion la
- 5y agoOCDXOrtho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021GlobeNewswireRARITAN, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it will report results for its second quarter 2021 ended July 4, 2021, after
- 5y agoABTBVAXFCEMIOCDX+1Covid-19 Tests Innovations Drawing New Interest from FDA and ConsortiumsPR NewswireVANCOUVER, B.C., July 22, 2021 /PRNewswire/ -- USA News Group - Two of the world's most prominent billionaires, George Soros and Bill Gates, recently made headlines backing a consortium to buy UK Covid-19 test maker Mologic for $41 million ahead o
- 5y agoOCDXOrtho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing MenuPR NewswireRARITAN, N.J., July 22, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition t
- 5y agoOCDXOrtho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use AuthorizationPR Newswire- Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians and public health leaders a standard tool to measu
- 5y agoOCDXOrtho Clinical Diagnostics Announces Partnership With Thermo Fisher ScientificPR NewswireRARITAN, N.J., July 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distribution agreement with Thermo Fisher Scientific™ to provide an
- 5y agoOCDXORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto RicoPR NewswireRARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion la
- 5y agoOCDXOrtho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody ResponsePR Newswire- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 - Ortho's new VITR
- 5y agoOCDXOrtho Clinical Diagnostics to Present at Upcoming Investor ConferencesGlobeNewswireRARITAN, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to present in two upc
- 5y agoOCDXOrtho Clinical Diagnostics Holdings plc (OCDX) Q1 2021 Earnings Call TranscriptEarnings Call TranscriptsOCDX earnings call for the period ending March 31, 2021.
- 5y agoOCDXOrtho Clinical Diagnostics Reports First Quarter 2021 ResultsGlobeNewswireRARITAN, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the first quarter ended April 4, 202
- 5y agoOCDXOrtho Clinical Diagnostics Holdings plc to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / May 5, 2021 / Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 5:00 PM Eastern Time. To listen to the event
- 5y agoOCDXOrtho Clinical Diagnostics Launches Quantitative COVID-19 IgG Antibody Test with CE MarkPR Newswire- Ortho's VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization of SARS-CoV-2 serological methods - The test give
- 5y agoOCDXGlobal Transfusion Medicine Leader Ortho Clinical Diagnostics Launches Next Gen ORTHO VISION® Swift PlatformPR NewswireORTHO VISION is the leading choice for blood banks RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enha
- 5y agoOCDXOrtho Clinical Diagnostics Recognized With Prestigious Edison Award for Highly Accurate COVID-19 Solutions Capable of Mass-Scale TestingPR NewswireRARITAN, N.J., April 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a prestigious silver 2021 Edison Award for its VITROS® COV
- 5y agoOCDXOrtho Clinical Diagnostics to Report First Quarter 2021 Results on May 5, 2021GlobeNewswireRARITAN, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2021 ended April 4, 2021, afte